This page contains a Flash digital edition of a book.
(a) and Ti = 1280o C (2336F).


(b)


Figure 9. (a) Eutectic cell density, N as a function undercooling, ∆Tm and (b) casting modulus, M C s1/2


for inoculated and base iron. Continuous lines are predicted results based on Eqns. (8) and (11), and Tables 1 and 2, for a = 0.11 J/cm2 o


(a) (12) and data from Tables 1 and 2 for a = 0.11 J/(cm2 o %C and 2.55 %Si. (Experimental point for ductile iron from Reference 37) , Ti = 1270o


• Type of spheroidizing agent and of the inoculation treatment—Table 2 shows the nucleation coeffi- cients for two different ductile iron melt treatments (Melts 1 and 2). Notice from Fig. 11, that the ex- perimental results are in good agreement with the


predicted nodule or cell counts as a function of ∆Tm or M (Eqns. 8 and 12).





Spheroidization and inoculation treatment temper- ature—the influence of the Mg treatment tempera- ture or of the inoculation temperature on the ex-


International Journal of Metalcasting/Summer 10 •


hibited nucleation coefficients is not known. How- ever, from the work of Merchant, 28


it is found that


a high temperature of bath superheating for a base iron destined for inoculation combined with a low inoculation temperature promotes a high graphite nodule count. A similar conclusion is valid for cast iron with flake graphite.38


Fading of inoculation—a characteristic feature of the inoculation process in cast iron is its fading ef- fect. Over time the substrates for active graphite


43


(b)


Figure 10. (a) The influence of added silicon from inoculant on cell and (b) the influence of the amount of inoculant, mi


on nodule count. Continuous lines are predicted results based on Eqn. C s1/2


C (2318F) in a melt with 3.66


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81